FBTvsLGHTETF Comparison
First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) belongs to the US Health Care segment. Langar Global HealthTech ETF (LGHT) is part of the Healthcare Technology segment. Both ETFs have the same top 3 sector exposures: and Health Care. FBT is less expensive with a Total Expense Ratio (TER) of 0.54%, versus 0.85% for LGHT. FBT is up 10.4% year-to-date (YTD) with +$1.12B in YTD flows. LGHT performs worse with -17.78% YTD performance, and -$926K in YTD flows. Run a side-by-side ETF comparison of FBT and LGHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FBT vs LGHT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBT LGHT | +8.63%-0.06% | +14.03%-8.22% | +10.40%-17.78% | +38.20%-19.78% | +44.56%n/a | +30.74%n/a |
| Flows | FBT LGHT | +$31M- | +$23M-$926K | +$1.12B-$926K | +$1.16B-$348K | +$677M- | +$382M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBT LGHT | +24.91%+22.07% | +21.21%+18.75% | +20.51%n/a | +22.00%n/a |
| Max drawdown | FBT LGHT | -4.56%-12.34% | -14.27%-25.58% | -19.92%n/a | -29.91%n/a |
| Max drawdown duration | FBT LGHT | 19d87d | 126d228d | 237dn/a | 1159dn/a |
FBT | LGHT | |
Last sale 6/15/2026 at 1:30 PM | $227.33 | $8.22 |
| Previous close 06/12/2026 | $225.61 | $8.21 |
| Consolidated volume 06/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FBT | LGHT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FBT | LGHT | |
|---|---|---|
| Last price | $227.33 | $8.22 |
| 1D performance | +0.76% | +0.10% |
| AuM | $2.63 B | $2.38 M |
| E/R | 0.54% | 0.85% |
FBT | LGHT | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | First Trust | Langar Investment Management |
| Benchmark | NYSE Arca Biotechnology Index | - |
| N° of holdings | 27 | 24 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | January 10, 2024 |
| ESG | No | Yes |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
